Combining Enzalutamide with Radium-223 Significantly Improves rPFS as First-Line Therapy for Patients with mCRPC By Ogkologos - August 27, 2025 453 0 Facebook Twitter Google+ Pinterest WhatsApp Findings from the PEACE-3 study Source RELATED ARTICLESMORE FROM AUTHOR FDA Approves Nivolumab with Chemotherapy for Previously Untreated Hodgkin Lymphoma 2026 ESMO Breast Cancer Award Recipient Announced Solid Organ Transplant Recipients with Pretransplant Cancer Have an Elevated Risk of Posttransplant Cancer of the Same Cancer Type MOST POPULAR Plant-Based Diets and a New Treatment Combination for Prostate Cancer: Research... February 16, 2023 Oncolytic Virus Enables the Immune System to Attack Tumors October 12, 2023 FDA Granted Accelerated Approval to Belantamab Mafodotin-blmf for Multiple Myeloma August 14, 2020 EMA Recommends Granting a Marketing Authorisation for Capmatinib May 13, 2022 Load more HOT NEWS Beating the Heat with Beets Findings support de-escalated radiotherapy after surgery in HPV-associated oropharyngeal squamous cell... Cancer Researchers Bring Tools, Experience to COVID-19 Studies World Cancer Research Day: Celebrating Progress in Treating and Caring for...
